Evidence map›Paper›PMID 39578962›Full record

ArticleChemistry & biodiversity2025

Neolignan Kadsurenin F Modulates Proteostatic Pathways and Possesses Potent Anti-Inflammatory Properties.

Zoi Evangelakou, Stefan Schwaiger, Despoina D Gianniou, Ioannis P Trougakos, Hermann Stuppner

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zoi EvangelakouDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, 15784, Greece.ORCID https://orcid.org/0000-0003-3433-5960
Stefan SchwaigerInstitute of Pharmacy/Pharmacognosy, University of Innsbruck, CCB, Innrain 80-82, 6020, Innsbruck, Austria.ORCID https://orcid.org/0000-0002-3731-7349
Despoina D GianniouDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, 15784, Greece.
Ioannis P TrougakosDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, 15784, Greece.ORCID https://orcid.org/0000-0002-6179-2772
Hermann StuppnerInstitute of Pharmacy/Pharmacognosy, University of Innsbruck, CCB, Innrain 80-82, 6020, Innsbruck, Austria.ORCID https://orcid.org/0000-0001-8862-0201

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kadsurenin F, a natural neolignan-type compound, has been described as a constituent of various members of the Lauraceae family such as Aniba spp. or Nectandra spp., but can also be found in various Piper species such as Piper kadsura Ohwi (Piperaceae). This species is traditionally used to treat asthma, rheumatic pain, arthritis, and digestive problems. Recently, several studies have highlighted the significant anti-inflammatory potential of P. kadsura extracts and secondary metabolites. Here, we report the isolation of kadsurenin F as an active component of P. kadsura. We found that kadsurenin F increases oxidative load and suppresses proteasome functionality in normal diploid human fibroblasts, and after administration in Drosophila flies. Moreover, kadsurenin F likely possesses anti-inflammatory properties, as apart from suppressing proteasome activity, it reversed inflammatory phenotypes and inhibited NO production in RAW 264.7 macrophage cells when administered in parallel with LPS. Our findings suggest that the kadsurenin F scaffold can be used for the development of novel highly bioactive proteasome inhibitors and/or anti-inflammatory compounds.

Indexed as

LignansProteasome Endopeptidase ComplexAnimalsAnti-Inflammatory AgentsDrosophilaFibroblastsHumansLipopolysaccharidesMacrophagesMiceNitric OxidePiperRAW 264.7 CellsStructure-Activity RelationshipAnti-Inflammatory AgentsLignansLipopolysaccharidesNitric OxideProteasome Endopeptidase ComplexAnti-inflammatoryDrosophila melanogasterKadsurenin FNF-κB pathwayProteasome inhibitor

Identifiers

PMID39578962
PMCPMC11908775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.